Navigation Links
ERBITUX(R) Meets Primary Endpoint of Increasing Survival in Phase III Lung Cancer Study
Date:9/10/2007

ncers, and now, with the FLEX data, for patients with advanced non-small cell lung cancer," said Martin Birkhofer, M.D., Vice President, Oncology Global Medical Affairs, Bristol-Myers Squibb. "We look forward to sharing these data with the medical community."

Results from this study will be submitted for presentation at an upcoming medical conference.

Merck KGaA, Darmstadt, Germany, is ImClone Systems' ERBITUX partner outside of North America.

About Lung Cancer

The American Cancer Society estimates that in the U.S., more than 213,000 people will be diagnosed with lung cancer in 2007. Lung cancer is the leading cause of cancer-related death in men and women in the U.S., with 160,000 deaths estimated in 2007. Approximately 80 to 85% of these patients will be diagnosed with non-small cell lung cancer, with the majority being diagnosed with locally advanced or metastatic disease.

About ERBITUX(R) (Cetuximab)

ERBITUX is a monoclonal antibody (IgG1 Mab) designed to inhibit the function of a molecular structure expressed on the surface of normal and tumor cells called the epidermal growth factor receptor (EGFR, HER1, c-ErbB-1). In vitro assays and in vivo animal studies have shown that binding of ERBITUX to the EGFR blocks phosphorylation and activation of receptor-associated kinases, resulting in inhibition of cell growth, induction of apoptosis, and decreased matrix metalloproteinase and vascular endothelial growth factor production. In vitro, ERBITUX can mediate antibody-dependent cellular cytotoxicity (ADCC) against certain human tumor types. While the mechanism of ERBITUX's anti-tumor effect(s) in vivo is unknown, all of these processes may contribute to the overall therapeutic effect of ERBITUX. EGFR is part of a signaling pathway that is linked to the growth and development of many human cancers, including those of the head and neck, colon and rectum.

ERBITUX (Cetuximab), in combination with radiation therapy, is indicated f
'/>"/>

SOURCE ImClone Systems Incorporated; Bristol-Myers Squibb Company
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. ENDEAVOR IV Clinical Trial Meets Primary Endpoint
2. Second Phase III Study Evaluating Gileads Viread for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint
3. Second Phase III Study Evaluating Gileads Viread for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint
4. Neoprobe Phase 2 Lymphoseek Trial Meets Primary Endpoint
5. Phase III Study Evaluating Gileads Viread for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint
6. SciClone and Sigma-Tau Report Thymalfasin Meets Primary Endpoint in Phase 2 Malignant Melanoma Trial
7. GlaxoSmithKline’s Hib-MenCY-TT Combination Vaccine Meets Phase II Study Endpoints of Immunogenicity and Safety Compared to Licensed Vaccines
8. YM BioSciences Reports AeroLEF Randomized Phase IIb Trial Meets Primary Endpoint in Patients with Post-Surgical Pain
9. DX-88 for Hereditary Angioedema Meets Primary and Secondary Endpoints in Phase 3 Trial (EDEMA3)
10. Alexzas AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating Schizophrenic Patients With Acute Agitation
11. Replidyne Phase II Pediatric Trial Meets Primary Objective
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... 2014   TRU-D SmartUVC LLC, producers of ... announced today that the General Services Administration has awarded ...   This newly formed agreement will allow ... government purchasers, including Department of Veteran Affairs and Department ... contacts purchasing solutions for the Ebola effort in ...
(Date:12/22/2014)... , Dec. 22, 2014 Cyberonics, Inc. (NASDAQ: ... the treatment and management of epilepsy, today announced it will ... Conference on Wednesday, January 14, 2015, in San ... President and Chief Executive Officer, will speak at 11:00 AM ... be accessed by clicking on the Investor Relations link on ...
(Date:12/22/2014)... Maine , Dec. 22, 2014  Mark ... analysis brief providing a summary of the 2015 ... plan enrollment trends.  According to ... for Planning and Evaluation, Department of Health and ... were enrolled in individual medical plans through the ...
Breaking Medicine Technology:TRU-D SmartUVC LLC Awarded General Services Administration Contract to Expand Government Customer Base 2Insights into the Marketplace and Individual Market Growth 2
... Watson Pharmaceuticals, Inc. (NYSE: WPI ) today ... Abbreviated New Drug Application (ANDA) with the U.S. Food ... Citrate Tablets, 25, 50 and 100 mg. Watson,s Sildenafil ... Viagra®, which is indicated for the treatment of erectile ...
... 2, 2011 DURECT Corporation (Nasdaq: DRRX ... Officer and Executive Vice President, Corporate Strategy has resigned ... Stauffer and DURECT have entered into a consulting agreement ... http://photos.prnewswire.com/prnh/20020717/DRRXLOGO ) "We appreciate all of Joe,s ...
Cached Medicine Technology:Watson Confirms Viagra® Patent Challenge 2DURECT Announces Resignation of Chief Medical Officer 2
(Date:12/26/2014)... CA (PRWEB) December 26, 2014 ... score of 3.1 out of 5. This score reflects ... low level of product specialization, low switching costs and ... is reduced by the low availability of substitutes for ... world price of steel and aluminum, key inputs in ...
(Date:12/26/2014)... (PRWEB) December 26, 2014 India Network ... insurance in the USA, announced today a new version ... members in choosing the right plan for their visiting ... complexity out of the selection process when choosing an ... age group with only a few clicks. Many elderly ...
(Date:12/25/2014)... December 26, 2014 This is a ... the global Sterilizers industry with a focus on the ... market status of the Sterilizers manufacturers and is a ... individuals interested in the industry. This report provides a ... and manufacturing technology. In this part, the report presents ...
(Date:12/25/2014)... “Every three months the trends for evening ... dress will be one of the hottest styles in the ... Today, the company releases 26 A-line sweetheart evening dresses, and ... , “We are trying our best to help a ... designs. Along with affordable prices, we provide discounted delivery costs ...
(Date:12/25/2014)... (PRWEB) December 25, 2014 BambooFlooringChina.com sells ... high quality bamboo flooring. Today, the company announces ... in many styles and colors. , BambooFlooringChina.com is the ... CEO, the promotion is valid until Jan. 20, 2015. ... strips and woven with a natural thread. All the ...
Breaking Medicine News(10 mins):Health News:Cooking & Warming Equipment Procurement Category Market Research Report from IBISWorld has Been Updated 2Health News:Cooking & Warming Equipment Procurement Category Market Research Report from IBISWorld has Been Updated 3Health News:India Network Health Insurance Announces new Comprehensive Pre-existing Condition Coverage policy for Visitors to the United States 2Health News:India Network Health Insurance Announces new Comprehensive Pre-existing Condition Coverage policy for Visitors to the United States 3Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 2Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 3Health News:Various Styles of Bamboo Mats in Many Colors from BambooFlooringChina.com 2
... Technologies Inc.,(TSX: NDQ), a developer of real-time medical imaging systems and ... and live webcast,to discuss the financial results for the third quarter ... November 5, 2007, Time: ... pm, Eastern Time, Dial in number: 416-644-3418 or 1-800-732-6179, ...
... 30 HearAtLast Holdings, Inc.,(Pink Sheets: HRAL) announced that ... owned subsidiary of Wal-Mart International, Inc.,(NYSE: WMT ), ... two,Toronto area Wal-Mart Stores. Wal-Mart Store #3195 located at ... #3053 located at 5000,Highway #7 Unit Y006A in Markham ...
... Toronto Stock Exchange Symbol: CYT, MONTREAL, ... the global leader in cryotherapy products to treat ... CEO of,CryoCath, will present at the 18th Annual ... York City on Tuesday, November 6. Mr. Keltjens ...
... Oct. 30 Anthera Pharmaceuticals,Inc., a privately held ... diseases, today announced,that Donald J. Santel has been ... experience in transforming early biotech startups into,commercial stage ... our pipeline,and move A-002 into large scale Phase ...
... with ThirdAge.com and Oral-B Triumph with SmartGuide to, Present ... Grant One ... Makeover of a Lifetime, CINCINNATI, Oct. 30, 2007 ... Mariel Hemingway to,educate baby boomers about the importance of maintaining ...
... Minutes of Your Day With New Crest ... Whitestrips Daily Multicare-, CINCINNATI, Oct. 30 ... do these activities have,in common? They only take five minutes. Now you ... five minute activities thanks to,an advancement in technology by Crest Whitestrips. As ...
Cached Medicine News:Health News:Novadaq announces third quarter 2007 conference call and webcast 2Health News:Novadaq announces third quarter 2007 conference call and webcast 3Health News:HearAtLast Continues Rapid Expansion, Opening Two New Retail Locations in Richmond Hill and Markham Wal-Mart Stores Number 3195 and 3053 2Health News:HearAtLast Continues Rapid Expansion, Opening Two New Retail Locations in Richmond Hill and Markham Wal-Mart Stores Number 3195 and 3053 3Health News:CryoCath to present at CIBC Healthcare Conference 2Health News:Anthera Pharmaceuticals, Inc. Appoints Donald Santel to Board of Directors 2Health News:Actress and Author Mariel Hemingway Guides Boomers on How to Make Their 'Third Age' a Healthy Age 2Health News:Actress and Author Mariel Hemingway Guides Boomers on How to Make Their 'Third Age' a Healthy Age 3Health News:Video: Grin Big With an Award-Winning Smile 2Health News:Video: Grin Big With an Award-Winning Smile 3
... Medical Office (EMO) truly built for the ... needs of your practice. The ChartLogic™ EMO ... system (EMR, EHR, and EPR), and then ... level of efficiency and performance. In addition ...
... Optical dispensing is a part of about ... we have created a point of sale system. ... alone program or it can be integrated to ... the national Frames database. Glasses prescriptions, if ...
... This program module functions stand alone. It ... the ophthalmicsuite product. The ASC module is ... in ophthalmic surgical specialty. Cataract, cosmetic, strabismus, ... The ASC forms are adapted to your ...
... ChartLogic is an Electronic Medical ... and customized for the needs of ... and storing your charts electronically, an ... flow including documentation of patient encounters, ...
Medicine Products: